Breast Cancer 2012 – New Aspects

Por Kolberg, H.-C., Lüftner, D., Lux, M. P., Maass, N., Schütz, F., Fasching, P. A., Fehm, T., Janni, W., Kümmel, S.
Publicado em 2012

Breast Cancer Update 2014 – Focus on the Patient and the Tumour

Por Maass, N., Schütz, F., Fasching, P. A., Fehm, T., Janni, W., Kümmel, S., Kolberg, H.-C., Lüftner, D., Wallwiener, M., Lux, M. P.
Publicado no Geburtshilfe Frauenheilkd (2015)

Advances in Breast Cancer – Looking Back over the Year

Por Lüftner, D., Lux, M. P., Maass, N., Schütz, F., Schwidde, I., Fasching, P. A., Fehm, T., Janni, W., Kümmel, S., Kolberg, H.-C.
Publicado no Geburtshilfe Frauenheilkd (2012)

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

Por Qiao, G-B, Wu, Y-L, Yang, X-N, Zhong, W-Z, Xie, D, Guan, X-Y, Fischer, D, Kolberg, H-C, Kruger, S, Stuerzbecher, H-W
Publicado em 2005

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study

Por Fasching, P. A., Fehm, T., Kellner, S., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H.-C., Guggenberger, M., Warm, M., Harbeck, N., Würstlein, R., Deuker, J.-U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H.-W., Breitbach, G.-P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesslet, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauß, T., Thomssen, C., Kümmel, S., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Hadji, P., Wallwiener, D., Grischke, E.-M., Beckmann, M. W., Brucker, S. Y.
Publicado no Geburtshilfe Frauenheilkd (2014)